Chair: Julio Croda, Fiocruz*
Chair:
Mauricio Zuma, Bio-Manguinhos / Fiocruz*
Speaker:
Rajinder Suri / DCVMN*
Discussants:
Adriansjah Azhari, Biofarma; Tiago Rocca, Butantan*; Venkatraman Sivaramakrishnan, BharatBiotech; Rachel Park, EuBiologics; Sunil Gairola, Serum Institute of India*; Andrew Wong, Walvax; Fernando Lobos, Sinergium Biotech
Chair:
Leda Castilho, UFRJ*
Prototype plant
Ricardo de Godoi Mattos Ferreira, Bio-Manguinhos / Fiocruz
Infrastructure to accelerate Innovation in vacines
Raches Ella, Bharat Biotec*
Chair:
Ricardo de Godoi, Bio-Manguinhos / Fiocruz
Vaccines for a safer world – the pitfalls in the development of vaccines for neglected diseases
Hayato Urabe, GHIT*
Managing innovation in human health biotechnology startups in Brazil: Evidence and lessons learned
Paulo Negreiros Figueiredo, FGV*
Chair:
Gustavo Mendes, Butantan
Chair:
Margareth Dalcolmo, Fiocruz
Wolbachia method: a powerful strategy for controlling arboviruses
Karlos Diogo Chalegre, Fiocruz
Clinical trials of a Dengue vaccine
Fernanda Castro Boulos, Butantan
Chair:
Milena Botelho Pereira Soares, Senai CIMATEC / Fiocruz-Bahia*
RNAi therapeutics: moving from the research to a reality
Jing-Tao Wu, Alnylam Pharmaceuticals*
Chair:
Akira Homma, Bio-Manguinhos / Fiocruz
Chair:
Maurício Zuma, Bio-Manguinhos / Fiocruz
Keynote speaker:
Sarah Gilbert, Oxford University*
Clinical trials of the coronavírus vaccine in Brazil
Sue Ann Costa Clemmens, Oxford University
